Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-24-100244
Filing Date
2024-09-16
Accepted
2024-09-16 16:40:28
Documents
7
Effectiveness Date
2024-09-16

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2332800d22_s8.htm S-8 58669
2 EXHIBIT 4.6 tm2332800d22_ex4-6.htm EX-4.6 104085
3 EXHIBIT 4.7 tm2332800d22_ex4-7.htm EX-4.7 84028
4 EXHIBIT 5.1 tm2332800d22_ex5-1.htm EX-5.1 6725
5 EXHIBIT 23.1 tm2332800d22_ex23-1.htm EX-23.1 2368
6 EX-FILING FEES tm2332800d22_ex-filingfees.htm EX-FILING FEES 20115
7 GRAPHIC tm2332800d22_ex5-1img001.jpg GRAPHIC 7543
  Complete submission text file 0001104659-24-100244.txt   287678
Mailing Address 1000 WINTER ST, SUITE 1200 WALTHAM MA 02451
Business Address 1000 WINTER ST, SUITE 1200 WALTHAM MA 02451 857-271-2954
Zenas BioPharma, Inc. (Filer) CIK: 0001953926 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-282151 | Film No.: 241301604
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)